Estudios originales

Characterization of the expressed and effective demand for oncology services under the explicit health guarantees of the Chilean public health system

Back to article
Rates of new cases, opportunity guarantees by health problem and sex, and male/female ratio between indicators.
Rate of new cases/1000 FONASA beneficiariesGO rate of primary treatment according to tracer intervention/1000 FONASA beneficiariesGO delayed/new cases*100
Health ProblemYearMaleFemaleRate M:FMaleFemaleRate M:FMaleFemaleRate M:F
Cancer pain relief and palliative care20181.531.391.101.531.381.110.200.320.62
20191.511.431.051.511.431.050.240.141.67
20201.461.361.081.461.361.080.240.390.61
20211.501.720.871.501.720.870.270.340.77
20221.661.541.081.651.531.080.410.291.42
Breast cancer in persons aged 15 years and older20180.022.220.010.010.770.010.834.060.21
20190.022.240.010.000.810.012.734.140.66
20200.011.770.010.000.690.002.336.910.34
20210.022.600.010.000.300.006.9010.840.64
20220.022.760.010.010.880.0111.9713.450.89
Preventive cholecystectomy for gallbladder cancer in people 35 to 49 years of age20184.1813.180.323.2610.750.301.381.800.76
20193.9912.270.323.089.840.311.271.300.98
20202.638.060.332.216.930.329.2311.090.83
20213.7611.440.333.009.610.3112.7115.620.81
20223.6411.320.322.879.650.309.6811.020.88
Gastric cancer20180.981.160.850.280.122.451.491.001.49
20190.931.180.780.260.122.091.871.111.68
20200.710.780.910.230.092.627.267.390.98
20210.811.280.630.230.121.879.659.491.02
20220.891.260.700.250.112.187.136.071.17
Colorectal cancer in persons 15 years of age and older20180.760.880.870.140.121.173.033.460.87
20190.881.100.800.160.141.113.763.241.16
20200.680.760.900.140.111.2310.269.681.06
20210.891.090.820.170.151.1310.389.481.09
20220.991.260.790.160.161.0411.4311.291.01
Lung cancer in people aged 15 years and older20190.110.091.220.040.031.206.526.670.98
20200.270.191.400.120.091.226.808.110.84
20210.330.261.270.040.031.258.829.970.88
20220.360.301.220.120.111.1612.5712.910.97

GO, guarantee of opportunity. H:M, male/female.

Data correspond to primary treatment timeliness guarantees by tracer intervention and delayed timeliness guarantees/new cases*100 for the country, years 2018 to 2022.

Source: Prepared by the authors of this study.